Altimmune ALT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$91.08M-3.4% | -$88.09M-5.0% | -$83.92M+4.4% | -$87.75M+2.8% | -$90.24M+5.1% | ||
| $106K-5.4% | $112K-5.9% | $119K-7.8% | $129K-19.4% | $160K-32.8% | ||
| $15.44M-4.0% | $16.08M+11.0% | $14.49M+3.4% | $14.01M-5.0% | $14.76M+2.5% | ||
| -$71.64M-6.1% | -$67.54M-1.8% | -$66.35M+18.7% | -$81.57M-1.5% | -$80.33M-0.6% | ||
| —— | —— | —— | —— | —— | ||
| -$131.06M+1.1% | -$132.47M— | —— | —— | —— | ||
| $251.2M+21.4% | $206.84M+52.3% | $135.8M+40.4% | $96.71M+118% | $44.42M+342% | ||
| —— | —— | —— | $120.53M+441% | -$35.33M+65.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Altimmune generate?
- Altimmune (ALT) generated -$71.6M in operating cash flow over the trailing twelve months.
- What is Altimmune's free cash flow?
- After $111.0K of capital expenditures, Altimmune's free cash flow was -$68.8M over the trailing twelve months, up 10.2% year over year.
- Where does Altimmune's cash flow data come from?
- Every line is extracted from Altimmune's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
